NGF and early-onset autosomal dominant Alzheimer disease: Numerous papers have proposed NGF as a possible therapeutic option in the treatment of Alzheimer’s disease (AD) due to its ability to sustain cholinergic activity [2,3,4] and its neuroprotective function [5,6], together with its ability to directly inhibit amyloidogenesis [7,8].